Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CellCept in Myasthenia Gravis
NCT00683969Phase 3Completed
- Sponsor
- Roche
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of mycophenolate mofetil in myasthenia gravis (MG), sponsored by Roche. Started Aug 2004; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on NCT00683969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00683969.